Facial soft tissue augmentation with Artecoll<sup>®</sup>: A review of eight years of clinical experience in 153 patients

Solomon, Philip; Sklar, Michael C.; Zener, Rebecca

doi:10.1177/229255031202000110

Cited by 34 publications

(43 citation statements)

References 19 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus, the average age of Chinese women in our study was 32 AE 5 years, compared with the average age of 45 AE 8 years of women in Europe and the United States who received botulinum toxin, hyaluronic acid, or Artecoll. 34 Ayoung face is rounded and firm, and the older face becomes longer and wrinkled and tends to sag. Using fillers at the right time provides women between 30 and 50 years with an additional decade of healthy look and self-confidence.…”

Section: Resultsmentioning

confidence: 99%

Facial Volume Restoration with Permanent Dermal Filler (Artecoll-4) in Chinese Women

Luo

Wang

et al. 2017

Facial plast Surg

View full text Add to dashboard Cite

Artecoll is the only permanent dermal filler to be approved by the European Union and China Food and Drug Administration, and has been used worldwide since 1994 in approximately 400,000 patients. Since 2002, Artecoll-4 has also been injected in China in more than 42,000 patients in more than 100 hospitals, primarily for beauty refinement in younger patients and for rejuvenation of the aging face. Artecoll-4 consists of polymethylmethacrylate (PMMA) microspheres (20% by volume) 40 µm in diameter, suspended in 3.5% bovine collagen solution and 0.3% lidocaine. The collagen carrier is absorbed rather early after injection and is completely replaced by the patient's own connective tissue within the first 3 months. Thus, in contrast to all other fillers, Artecoll-4 becomes the patient's own tissue, and it is a “living implant.” In this study, a total of 10,725 patients were treated in 25 Chinese cosmetic hospitals between 2007 and 2012. Optimal injection techniques, efficiency and lasting duration, complications, safety, outcome, and statistical results are discussed. The data support the safety and efficiency of large volumes of Artecoll-4 (5–10 mL) injected deep into the faces of Chinese women, who seek to have a smooth oval face without indentations. No foreign body granulomas have been reported since the recommendation for strict epiperiosteal injections. Level of evidence is Level IV, multiple center study.

show abstract

Section: Resultsmentioning

confidence: 99%

Facial Volume Restoration with Permanent Dermal Filler (Artecoll-4) in Chinese Women

Luo

Wang

et al. 2017

Facial plast Surg

View full text Add to dashboard Cite

show abstract

“…The Arnett analysis in soft tissue could provide a tool to optimally analyze and correct esthetic disharmonies. Assuming that, the soft‐tissue Arnett analysis points have been used in this study, to perform clinical measurements . Taking as reference the true vertical line (TVL), a line running from the subnasal point in NHP, we monitored the sagittal pre‐ and posttreatment distance of the following soft‐tissue points: Forehead (F), Glabella (Gb), Nasion (Na), Nasal dorsum (Nd), Nasal tip (Nt), Subnasal (Sn), Upper lip anterior (ULA), Lower lip anterior (LLA), Soft‐tissue point B (B), Pogonion (Pg), and Gnathion (Gn) (Figure ).…”

Section: Methodsmentioning

confidence: 99%

“…Assuming that, the soft-tissue Arnett analysis points have been used in this study, to perform clinical measurements. 14 Taking as reference the true vertical line (TVL), a line running from the subnasal point in NHP, 13,14 we monitored the sagittal pre-and posttreatment distance of the following soft-tissue points: Forehead (F), Glabella (Gb), Nasion (Na), Nasal To evaluate the effect of the treatment on quality of life (QoL) and to assess patient satisfaction about the treatment, patients were given a FACE-Q instrument to complete pre-and 90 days posttreatment. We use the FACE-Q Satisfaction with Facial Appearance ( Figure S1).…”

Section: Methodsmentioning

confidence: 99%

Injectable profiloplasty: Forehead, nose, lips, and chin filler treatment

Bertossi

Lanaro

Dell'Acqua

et al. 2018

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Summary Introduction We propose a medical filler treatment algorithm of the profile which includes forehead, nose, and chin and to evaluate profilometric results and complications. Materials and Methods 83 case reviews of associated liquid forehead, nose, and chin plasty performed consecutively from 2014 to 2016. We monitored the horizontal and vertical sagittal stability into two age group: <40 y.o. and >40 y.o. using profilometric Arnett analysis measurements on the F, Gb, Na, Nd, Nt, Sn, ULA, LLA, B, Pg, and Gn soft‐tissue points. Results The results at both 3 and 6 months were consistent with the normal ranges indicated by Arnett, with a 0.8 mm maximum of defect/excess. Forehead treatment was performed in 51 (61.4%) patient. Patients >40 y.o. always needed a global correction of the forehead profile. We performed nasal treatment in 83 (100%) patient, acute nasolabial angles was the more frequent nasal defect. The lips were injected in 59 patients (71.1) more frequently >40 y.o. In 83 (100%) patients we perform a chin augmentation. The average advancement of the chin was 3 mm. Conclusions The correction of the projection of the forehead, of the profile and shape of the nose, of the lips and chin as well as an overall improvement in face aesthetics and harmony gives a good solution in patients avoiding the need for a surgical intervention, scars and cost of general anesthesia, thus providing the optimum in patient satisfaction.

show abstract

“…Methacrill and Metrex are also PMMA particles though not round and polished. Although granulomas are rare with 0.01% reported (Cohen et al, ; Solomon, Sklar, & Zener, ) they do occur and are difficult to treat (Haneke, ). Lumps often form, particularly in the lips, but most are just palpable and not visible.…”

Section: Soft Tissue Fillersmentioning

confidence: 99%

Adverse effects of fillers

Haneke

2018

Dermatologic Therapy

View full text Add to dashboard Cite

Filler injections belong to the most frequently performed noninvasive beautifying procedures. When done correctly they are generally well tolerated. However, a number of factors, such as poor filler quality, and particularly host as well as user dependent filler reactions may lead to unwanted effects. These may be early, late, or delayed events with characteristics for each of them. Temporary fillers almost invariably cause temporary side effects whereas those of permanent fillers may last forever. Some fillers are notorious for their poor safety profile; for example, silicone is banned in the European Union and the United States but nevertheless used by many practitioners and beauticians. Many fillers can be identified in histopathologic sections allowing specific measures to be instituted.

show abstract

Facial soft tissue augmentation with Artecoll^®: A review of eight years of clinical experience in 153 patients

Cited by 34 publications

References 19 publications

Facial Volume Restoration with Permanent Dermal Filler (Artecoll-4) in Chinese Women

Facial Volume Restoration with Permanent Dermal Filler (Artecoll-4) in Chinese Women

Injectable profiloplasty: Forehead, nose, lips, and chin filler treatment

Adverse effects of fillers

Contact Info

Product

Resources

About

Facial soft tissue augmentation with Artecoll®: A review of eight years of clinical experience in 153 patients

Cited by 34 publications

References 19 publications

Facial Volume Restoration with Permanent Dermal Filler (Artecoll-4) in Chinese Women

Facial Volume Restoration with Permanent Dermal Filler (Artecoll-4) in Chinese Women

Injectable profiloplasty: Forehead, nose, lips, and chin filler treatment

Adverse effects of fillers

Contact Info

Product

Resources

About

Facial soft tissue augmentation with Artecoll^®: A review of eight years of clinical experience in 153 patients